We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 533

Competition law scrutiny of patent settlements a new focus in Australia?
  • DLA Piper LLP
  • Australia
  • October 24 2016

Settlement agreements in patent disputes between pharmaceutical companies may soon face greater competition law scrutiny in Australia. The

Doing business in Australia: An introductory guide
  • PwC Australia
  • Australia, Global, OECD
  • October 20 2016

Australia is the world's sixth largest country, comprising an area of approximately 7.7 million square kilometres. It is a vast continent covering a

Doing Business in Australia
  • Baker & McKenzie
  • OECD, USA, Australia, Global, Hong Kong
  • September 7 2016

The Commonwealth of Australia comprises a federation of six States: New South Wales, Queensland, South Australia, Tasmania, Victoria and Western

AMA welcomes ACCC legal action against Medibank Private
  • Russell Kennedy
  • Australia
  • July 29 2016

The Australian Medical Association ("AMA") has welcomed the Australian Competition and Consumer Commission's ("ACCC") decision to commence legal

Misuse of market power: How proposed changes to the law will affect the private health insurance sector
  • DLA Piper LLP
  • Australia
  • April 6 2016

The Turnbull Government recently announced that it will adopt the Harper Review's recommendation to amend section 46 of the Competition and Consumer

Australian health sector remains under ACCC spotlight in 2016
  • DLA Piper LLP
  • Australia
  • March 17 2016

The Australian Competition and Consumer Commission (ACCC) recently released its enforcement priorities for 2016. Each year, the ACCC nominates its

Major trends give rise to competition concerns in the Australian life sciences sector
  • DLA Piper LLP
  • Australia
  • December 1 2015

Many of the global challenges encountered by the life sciences sector in recent years have emerged in Australia. Consistent with the global outlook

RK health insights 19 November 2015
  • Russell Kennedy
  • Australia
  • November 19 2015

The Federal Government is set to remove 17 common over-the-counter medicines (including paracetamol and aspirin) from the Pharmaceutical Benefits

Regulating the nip and tuck: cosmetic medical services growth expands
  • Maddocks
  • Australia
  • May 21 2015

Cosmetic medicine is one of Australia's fastest growing consumer markets, yet the AUD $1 billion1 consumer market is largely unregulated. On the

Harper Review dispenses important recommendations for the life sciences sector
  • DLA Piper LLP
  • Australia
  • May 6 2015

The long-awaited Harper Review final report was released on 31 March 2015. This update highlights key recommendations relevant to the life sciences